The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 08, 2020

Filed:

Sep. 05, 2014
Applicant:

President and Fellows of Harvard College, Cambridge, MA (US);

Inventors:

David R. Liu, Lexington, MA (US);

John Paul Guilinger, Ridgway, CO (US);

David B. Thompson, Cambridge, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/12 (2006.01); C12N 9/22 (2006.01); A61K 38/46 (2006.01); C07K 14/315 (2006.01); C12N 15/90 (2006.01); C12N 15/01 (2006.01); A61K 38/00 (2006.01); A61K 47/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/22 (2013.01); A61K 38/465 (2013.01); C07K 14/315 (2013.01); C12N 9/1241 (2013.01); C12N 15/01 (2013.01); C12N 15/907 (2013.01); A61K 38/00 (2013.01); A61K 47/00 (2013.01); C07K 2319/80 (2013.01);
Abstract

Some aspects of this disclosure provide compositions, methods, and kits for improving the specificity of RNA-programmable endonucleases, such as Cas9. Also provided are variants of Cas9, e.g., Cas9 dimers and fusion proteins, engineered to have improved specificity for cleaving nucleic acid targets. Also provided are compositions, methods, and kits for site-specific nucleic acid modification using Cas9 fusion proteins (e.g., nuclease-inactivated Cas9 fused to a nuclease catalytic domain or a recombinase catalytic domain). Such Cas9 variants are useful in clinical and research settings involving site-specific modification of DNA, for example, genomic modifications.


Find Patent Forward Citations

Loading…